IL82223A0 - Coatable ion exchange resins,their complexes with drugs and pharmaceutical compositions containing them - Google Patents

Coatable ion exchange resins,their complexes with drugs and pharmaceutical compositions containing them

Info

Publication number
IL82223A0
IL82223A0 IL82223A IL8222387A IL82223A0 IL 82223 A0 IL82223 A0 IL 82223A0 IL 82223 A IL82223 A IL 82223A IL 8222387 A IL8222387 A IL 8222387A IL 82223 A0 IL82223 A0 IL 82223A0
Authority
IL
Israel
Prior art keywords
coatable
complexes
drugs
pharmaceutical compositions
ion exchange
Prior art date
Application number
IL82223A
Other languages
English (en)
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of IL82223A0 publication Critical patent/IL82223A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Laminated Bodies (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Pyridine Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
IL82223A 1986-07-30 1987-04-16 Coatable ion exchange resins,their complexes with drugs and pharmaceutical compositions containing them IL82223A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89216986A 1986-07-30 1986-07-30

Publications (1)

Publication Number Publication Date
IL82223A0 true IL82223A0 (en) 1987-10-30

Family

ID=25399487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82223A IL82223A0 (en) 1986-07-30 1987-04-16 Coatable ion exchange resins,their complexes with drugs and pharmaceutical compositions containing them

Country Status (13)

Country Link
EP (1) EP0254811B1 (fr)
JP (1) JP2670777B2 (fr)
KR (1) KR960012067B1 (fr)
AT (1) ATE93164T1 (fr)
AU (1) AU582302B2 (fr)
CA (1) CA1283998C (fr)
DE (1) DE3787060T2 (fr)
DK (1) DK394787A (fr)
FI (1) FI872582L (fr)
IE (1) IE62100B1 (fr)
IL (1) IL82223A0 (fr)
NO (1) NO873031L (fr)
NZ (1) NZ219816A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
SE9003903D0 (sv) * 1990-12-07 1990-12-07 Astra Ab New pharmaceutical formulations
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
US5296228A (en) * 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
JP3213712B2 (ja) * 1992-08-04 2001-10-02 全日本空輸株式会社 コンテナ自動移載装置および移載方法
JPH06305518A (ja) * 1993-04-23 1994-11-01 Kajima Corp 収納設備
WO1999020285A1 (fr) * 1997-10-16 1999-04-29 Sanwa Kagaku Kenkyusho Co., Ltd. Preparations de gels contenant un polystyrenesulfonate
US6280717B1 (en) * 1998-07-31 2001-08-28 Nikken Chemicals Co., Ltd. Cation exchange resin preparation
JP3866179B2 (ja) 2002-10-09 2007-01-10 ダイセル化学工業株式会社 光学異性体分離用充填剤の製造方法
JP4808405B2 (ja) 2002-11-26 2011-11-02 ホ−レンベック ギャリ− ア−ル 高度に水溶性の電解質薬剤のための水性徐放性ドラッグデリバリーシステム
CA2537607A1 (fr) 2003-09-03 2005-03-17 Mallinckrodt Inc. Preparation granulaire a liberation prolongee et production de cette preparation
JP2008543751A (ja) * 2005-06-09 2008-12-04 ユーピーエム ファルマセウチカルス インコーポレーテッド 易水溶性電解質薬物のための水性徐放性薬物送達システム
US8343546B2 (en) * 2005-09-13 2013-01-01 Coating Place, Inc. Ion exchange resin treated to control swelling
WO2007038801A2 (fr) * 2005-09-30 2007-04-05 Ilypsa, Inc. Compositions de liaison aux cations monovalents comprenant des particules coeur-ecorce avec des ecorces polyvinyliques reticulees et procedes pour les utiliser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
CA1236023A (fr) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Preparations pharmaceutiques a liberation controlee
NZ219925A (en) * 1986-07-30 1989-06-28 Pennwalt Corp Polymer-treated sulphonic acid cationic exchange resin particles

Also Published As

Publication number Publication date
NO873031D0 (no) 1987-07-20
DE3787060T2 (de) 1993-12-02
JPS6335527A (ja) 1988-02-16
IE62100B1 (en) 1994-12-14
JP2670777B2 (ja) 1997-10-29
FI872582A0 (fi) 1987-06-09
NZ219816A (en) 1989-01-06
AU582302B2 (en) 1989-03-16
AU7098987A (en) 1988-02-04
ATE93164T1 (de) 1993-09-15
DK394787A (da) 1988-05-02
KR880001302A (ko) 1988-04-22
EP0254811B1 (fr) 1993-08-18
CA1283998C (fr) 1991-05-07
NO873031L (no) 1988-02-01
FI872582A7 (fi) 1988-01-31
IE870789L (en) 1988-01-30
DE3787060D1 (de) 1993-09-23
EP0254811A3 (en) 1989-04-05
KR960012067B1 (ko) 1996-09-12
EP0254811A2 (fr) 1988-02-03
DK394787D0 (da) 1987-07-29
FI872582L (fi) 1988-01-31

Similar Documents

Publication Publication Date Title
AU582302B2 (en) Coatable ion exchange resins
EP0155705A3 (en) Antitumor platinum complexes
IL77395A (en) Pharmaceutical compositions containing 1-benzo-fused heterocyclyl)-piperazine derivatives,certain such novel compounds and their preparation
EP0206567A3 (en) Compounds of formula û1,1'-biphenyl¨-2-carboxylic acid, 2'-ûûû(substituted)phenyl¨-(substituted)amino¨carbonyl¨-, pharmaceutical compositions comprising the compounds, and a process for preparing the compounds
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
ZA859035B (en) Amino-salicylic acid derivatives,salts thereof,process for their preparation and pharmaceutical compositions containing them
GR3025268T3 (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
IL58643A (en) Process for the preparation of 1-hydroxylated vitamin d compounds and pharmaceutical compositions comprising a 1 alpha-hydroxy-5,6-cis-bitamin d compound
PT84399B (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
IL82426A0 (en) Polymer-treated ion exchange resins and pharmaceutical compositions containing them
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
LTIP1682A (en) Novel 16,17-acetal-substituted derivatives of pregnan-21-oic acid, process for preparing thereof, pharmaceutical preparations containing them
AU555496B2 (en) Phenoxypyridine ffor normalizing hippocampal function
DE3372772D1 (en) Quinazolinone derivatives, process for their preparation and their use in medicaments
HK69890A (en) Pharmaceutical compositions containing reduced glutathione
ES8801291A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
ES8602610A1 (es) Procedimiento para la preparacion de sales de carnitina del acido alfa-glucoso-1-fosforico
HUT39731A (en) Process for preparing arphamenine derivatives and pharmaceutical compositions containing such compounds
HUT35694A (en) Process for producing 2'-deoxy-oxanosine and pharmaceutical compositions containing them
DE3461924D1 (en) 1,3-bis(dimethylamino)-2-propyl-4-chlorophenoxyacetate, its addition salts, process for its production and pharmaceutical preparations containing the afore-mentioned compounds
IL78186A (en) Pharmaceutical compositions containing 3-alkyl-5,6-dihydroimidazo-isoquinoline and imidazothienopyridine-carboxylic acid derivatives,some such new compounds and their preparation